CD86 and neoplasm: Previous studies have demonstrated that up-regulation of CD80 and CD86 in the tumor vaccine systems can successfully improve the immunogenicity of vaccines due to the effect of costimulatory CD80 and CD86 molecules on tumor immunity (48).